Aquestive Therapeutics logo

Aquestive Therapeutics

AQST | NASDAQ
Chart Builder DCF Calculator
$3.76
-$0.15 (-3.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.78
+$0.02 (+0.53%)
After-hours: Nov 16, 2026, 7:55 PM ET
-3.84%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
36.8
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #608/1021 (Top 60%)

Key Statistics

Market Data

Market Cap $472.59M
1D Range
3.71 3.95
52W Range
2.95 6.62

Valuation (TTM)

PE -5.87
PB -6.67
EV/EBITDA -6.02

Valuation (NTM)

Forward PE N/A
Forward PEG 0.25
Price Target $10.50
Loading financial charts...

Profile

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and i...

Sector Healthcare
Employees 147
IPO Date Jul 25, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 3, 2026
EPS
-$0.13
Miss -8.33%
REV
$7.56M
Miss -31.41%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$10.50
Upside
+179.26%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.